Share:
U.S. FDA Granted Fast Track Designation in 2018
Trial Expected to Enroll 300-400 Patients at Approximately 165 Sites in the U.S. and Europe in Simplified Adaptive Trial Design
Conference Call and Webcast Today at 8:30 a.m. ET
HOUSTON, April 27, 2021 (GLOBE NEWSWIRE) Aravive Inc. (NASDAQ:ARAV), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, today announced the Company has dosed the first patient in its Phase 3 trial of AVB-500 in platinum resistant ovarian cancer (PROC). The trial is evaluating the efficacy of AVB-500 in combination with paclitaxel (chemotherapy) and the primary endpoint is progression free survival.
Session Time: April 13, 11:17-11:39 a.m. EST
Summary: Kaelin will highlight the important physiologic constraints a cancer tissue must operate within, focusing on the critical role hypoxia plays in not only tumor growth but progression, and how modulating the hypoxia machinery will limit tumor progression. The ability to target cancer at several molecular levels provides hope that our therapies will not only be more effective but also more durable. The lingering question is how to deploy these approaches by identifying which patients are most likely to benefit.
In addition to the exciting research presentations, Andrew Aguirre, MD, PhD, of the Dana-Farber Center for Gastrointestinal Oncology, has been named a 2021 AACR NextGen Star. Aguirre will present during the NextGen Stars Spotlight Session: Genetics and Epigenetics.
By Logan Rude
MADISON, Wis. The search for a Barry Alvarez’s replacement has begun.
Alvarez announced announced his retirement Tuesday after more than 30 years with the university. He spent 17 of those years as athletic director. Now, a nine-member committee, chaired by UW Athletic Board Chair Peter Miller, will conduct the search for Alvarez’s replacement.
“We look forward to a robust and extensive search to identify the best candidate to lead the UW Athletic Department forward,” Miller said.
University officials said a new director of athletics could be hired by this summer.
UW-Madison Chancellor Rebecca Blank said Alvarez’s replacement “should be able to continue his legacy of success and make our alumni and fans across the state proud.”
MADISON, Wis. The search for a Barry Alvarez’s replacement has begun.
Alvarez announced announced his retirement Tuesday after more than 30 years with the university. He spent 17 of those years as athletic director. Now, a nine-member committee, chaired by UW Athletic Board Chair Peter Miller, will conduct the search for Alvarez’s replacement.
“We look forward to a robust and extensive search to identify the best candidate to lead the UW Athletic Department forward,” Miller said.
University officials said a new director of athletics could be hired by this summer.
UW-Madison Chancellor Rebecca Blank said Alvarez’s replacement “should be able to continue his legacy of success and make our alumni and fans across the state proud.”
Poster on Celsion Corporation s (CLSN) Phase I/II OVATION 2 Study Presented at the Society of Gynecologic Oncology Virtual Annual Meeting on Women s Cancer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.